Equillium to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Equillium (Nasdaq: EQ) said members of management will participate in two investor events in November 2025: a company presentation and 1x1 meetings at the Stifel Healthcare Conference on Wednesday, November 12, 2025, 3:20–3:50 PM EDT, and 1x1 meetings at the Jefferies Global Healthcare Conference in London from November 18–20, 2025.

Management will meet with registered investors and the public can listen to a live webcast of the Stifel presentation via the Events & Presentations page under Investor Relations at equilliumbio.com. An archived replay of both presentations will be available for 90 days.

News Market Reaction – EQ

-7.10%

12 alerts

-7.10% Session close to close

+4.2% Peak Tracked

-13.2% Trough Tracked

$85.68M Market Cap

0.9x Rel. Volume

In the Nov 4 session, EQ declined 7.10%, reflecting a notable negative market reaction. Argus tracked a peak move of +4.2% during that session. Argus tracked a trough of -13.2% from its starting point during tracking. Our momentum scanner triggered 12 alerts that day, indicating notable trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

LA JOLLA, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop novel therapeutics to treat severe autoimmune and inflammatory disorders, today announced that management will participate in the following upcoming investor conferences:

Stifel Healthcare Conference
Format:	Company Presentation & 1x1 Meetings
Date:	Wednesday, November 12, 2025
Time:	3:20-3:50 PM EDT

Jefferies Global Healthcare Conference in London
Format:	1x1 Meetings
Date:	Tuesday, November 18 – Thursday, November 20, 2025

Members of the Equillium management team will be available to participate in meetings with investors who are registered to attend the conference.

Investors and the general public are invited to listen to a live webcast of the presentation on the Events & Presentations page, located under the Investor Relations section on equilliumbio.com. An archived replay of both presentations will be available for 90 days.

About Equillium
Equillium is a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop novel therapeutics to treat severe autoimmune and inflammatory disorders with high unmet medical need. The company’s pipeline consists of several novel immunomodulatory assets and product platform targeting immuno-inflammatory pathways. 

For more information, visit www.equilliumbio.com.

Investor Contact
PJ Kelleher
LifeSci Advisors, LLC
+1-617-430-7579
pkelleher@lifesciadvisors.com

FAQ

When will Equillium (EQ) present at the Stifel Healthcare Conference?

Equillium will present on Wednesday, November 12, 2025 from 3:20–3:50 PM EDT.

How can I watch Equillium's (EQ) Stifel presentation webcast?

The live webcast will be available on the Events & Presentations page under Investor Relations at equilliumbio.com.

Will Equillium (EQ) attend the Jefferies Global Healthcare Conference in London?

Yes. Equillium management will hold 1x1 meetings at the Jefferies conference from November 18–20, 2025.

How long will Equillium (EQ) presentation replays be available?

Archived replays of both presentations will be available for 90 days.

Do I need to register to meet Equillium (EQ) management at these conferences?

Yes. Meetings are available to investors who are registered to attend the respective conferences.

Where can investors find details about Equillium (EQ) conference appearances?

Details and access to webcasts are posted on the company's Investor Relations → Events & Presentations page at equilliumbio.com.